Article info
PDFClinical science
Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial
- Correspondence to Dr Usha Chakravarthy, Center for Experimental Medicine, Queen’s University of Belfast, Belfast BT12 6BA, UK; u.chakravarthy{at}qub.ac.uk
Citation
Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial
Publication history
- Received January 5, 2018
- Accepted May 25, 2018
- First published June 21, 2018.
Online issue publication
May 07, 2023
Article Versions
- Previous version (7 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.